• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于液体活检应用的新兴传感技术:向个性化医疗迈进的步伐。

Emerging Sensing Technologies for Liquid Biopsy Applications: Steps Closer to Personalized Medicine.

作者信息

Kalligosfyri Panagiota M, Lamprou Eleni, Kalogianni Despina P

机构信息

Department of Chemistry, University of Patras, GR26504 Patras, Greece.

出版信息

Sensors (Basel). 2024 Dec 11;24(24):7902. doi: 10.3390/s24247902.

DOI:10.3390/s24247902
PMID:39771639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11678935/
Abstract

Liquid biopsy is an efficient diagnostic/prognostic tool for tumor-derived component detection in peripheral circulation and other body fluids. The rapid assessment of liquid biopsy techniques facilitates early cancer diagnosis and prognosis. Early and precise detection of tumor biomarkers provides crucial information about the tumor that guides clinicians towards effective personalized medicine. Point-of-care-testing remains still a great challenge in cancer diagnostics. Liquid biopsy is a promising alternative to tissue biopsy with the great advantages of less invasion and real-time monitoring of the disease, also providing information about tumor heterogeneity. The field is continuously and rapidly expanding. Numerous sophisticated biosensors have been developed targeting several biomarkers to achieve low detection limits, increased specificity and robustness. Current biosensors include mainly optical sensors, such as colorimetric, fluorescent, SPR, SERS and lateral flow assays. Electrochemical sensors have also been developed, providing very low detection limits. Colorimetric sensors exhibited simplicity in signal interpretation, while fluorescent sensors contributed to low analysis times, and SPR/SERS enabled label-free and rapid analysis. Novel target amplification and signal enhancement techniques have been exploited to increase the detectability of the sensors. In this context, this review is focused on the recent advances in biosensing technology for cutting-edge liquid biopsy applications towards point-of-care testing.

摘要

液体活检是一种用于在外周循环和其他体液中检测肿瘤衍生成分的高效诊断/预后工具。液体活检技术的快速评估有助于癌症的早期诊断和预后判断。肿瘤生物标志物的早期精确检测可为肿瘤提供关键信息,指导临床医生实施有效的个性化医疗。即时检测在癌症诊断中仍然是一个巨大的挑战。液体活检作为组织活检的一种有前景的替代方法,具有侵入性小和可实时监测疾病等巨大优势,还能提供有关肿瘤异质性的信息。该领域正在持续快速发展。为了实现低检测限、提高特异性和稳健性,针对多种生物标志物已开发出众多先进的生物传感器。当前的生物传感器主要包括光学传感器,如比色法、荧光法、表面等离子体共振(SPR)、表面增强拉曼光谱(SERS)和侧向流动分析。电化学传感器也已被开发出来,具有极低的检测限。比色传感器在信号解读方面表现出简单性,而荧光传感器有助于缩短分析时间,SPR/SERS则能够实现无标记快速分析。已采用新型目标扩增和信号增强技术来提高传感器的可检测性。在此背景下,本综述聚焦于用于即时检测的前沿液体活检应用的生物传感技术的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/5845aff045d9/sensors-24-07902-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/4ab0bd354990/sensors-24-07902-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/3465c1a03726/sensors-24-07902-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/f7dc77a85f79/sensors-24-07902-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/592fcf1d1e61/sensors-24-07902-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/821c69ff716b/sensors-24-07902-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/5845aff045d9/sensors-24-07902-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/4ab0bd354990/sensors-24-07902-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/3465c1a03726/sensors-24-07902-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/f7dc77a85f79/sensors-24-07902-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/592fcf1d1e61/sensors-24-07902-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/821c69ff716b/sensors-24-07902-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d307/11678935/5845aff045d9/sensors-24-07902-g006.jpg

相似文献

1
Emerging Sensing Technologies for Liquid Biopsy Applications: Steps Closer to Personalized Medicine.用于液体活检应用的新兴传感技术:向个性化医疗迈进的步伐。
Sensors (Basel). 2024 Dec 11;24(24):7902. doi: 10.3390/s24247902.
2
Recent Advances in Exosomal Protein Detection Via Liquid Biopsy Biosensors for Cancer Screening, Diagnosis, and Prognosis.液体活检生物传感器在癌症筛查、诊断和预后中通过外泌体蛋白检测的最新进展。
AAPS J. 2018 Mar 8;20(2):41. doi: 10.1208/s12248-018-0201-1.
3
Recent advances in nanotechnology-enabled biosensors for detection of exosomes as new cancer liquid biopsy.纳米技术增强型生物传感器在检测外泌体作为新型癌症液体活检中的最新进展。
Exp Biol Med (Maywood). 2022 Dec;247(23):2152-2172. doi: 10.1177/15353702221110813. Epub 2022 Aug 6.
4
Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems.迈向个性化癌症治疗:微型电动力学系统中的诊断到治疗监测。
Acc Chem Res. 2019 Aug 20;52(8):2113-2123. doi: 10.1021/acs.accounts.9b00192. Epub 2019 Jul 11.
5
Liquid biopsy and its role in an advanced clinical trial for lung cancer.液体活检及其在肺癌晚期临床试验中的作用。
Exp Biol Med (Maywood). 2018 Feb;243(3):262-271. doi: 10.1177/1535370217750087.
6
Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.超越循环肿瘤细胞和游离DNA的液体活检
Acta Cytol. 2019;63(6):479-488. doi: 10.1159/000493969. Epub 2019 Feb 15.
7
Liquid biopsy for early cancer detection: technological revolutions and clinical dilemma.液体活检在早期癌症检测中的应用:技术革命与临床困境
Expert Rev Mol Diagn. 2024 Oct;24(10):937-955. doi: 10.1080/14737159.2024.2408744. Epub 2024 Oct 3.
8
Optical, electrochemical and electrical (nano)biosensors for detection of exosomes: A comprehensive overview.用于外泌体检测的光学、电化学和电(纳)生物传感器:全面综述。
Biosens Bioelectron. 2020 Aug 1;161:112222. doi: 10.1016/j.bios.2020.112222. Epub 2020 Apr 21.
9
Tailored point-of-care biosensors for liquid biopsy in the field of oncology.面向肿瘤学领域液体活检的个体化即时生物传感器。
Lab Chip. 2022 Dec 20;23(1):44-61. doi: 10.1039/d2lc00666a.
10
Advances in exosome plasmonic sensing: Device integration strategies and AI-aided diagnosis.外泌体等离子体传感的进展:器件集成策略与人工智能辅助诊断。
Biosens Bioelectron. 2024 Dec 15;266:116718. doi: 10.1016/j.bios.2024.116718. Epub 2024 Aug 30.

引用本文的文献

1
First Decade of the National Cancer Institute's Affordable Cancer Technologies Program: Accelerating Translational Technology Research and Development for Cancer Globally.美国国立癌症研究所可负担癌症技术项目的首个十年:加速全球癌症转化技术研发
JCO Glob Oncol. 2025 Jul;11:e2500200. doi: 10.1200/GO-25-00200. Epub 2025 Jul 30.
2
Molecular Diagnostics in Heart Failure: From Biomarkers to Personalized Medicine.心力衰竭中的分子诊断:从生物标志物到个性化医疗。
Diagnostics (Basel). 2025 Jul 17;15(14):1807. doi: 10.3390/diagnostics15141807.
3
Recent Advances in Fluorescence Resonance Energy Transfer (FRET) Biosensors for Exosomes.

本文引用的文献

1
Recent advances in ctDNA detection using electrochemical biosensor for cancer.使用电化学生物传感器检测癌症患者循环肿瘤DNA的研究进展
Discov Oncol. 2024 Oct 2;15(1):517. doi: 10.1007/s12672-024-01365-7.
2
Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review).液体活检:循环肿瘤DNA综述(综述)
Oncol Lett. 2024 Sep 13;28(5):548. doi: 10.3892/ol.2024.14681. eCollection 2024 Nov.
3
CRISPR-based dual-aptamer proximity ligation coupled hybridization chain reaction for precise detection of tumor extracellular vesicles and cancer diagnosis.
用于外泌体的荧光共振能量转移(FRET)生物传感器的最新进展
Curr Issues Mol Biol. 2025 Mar 28;47(4):235. doi: 10.3390/cimb47040235.
基于 CRISPR 的双适体邻近连接耦联杂交链式反应用于精确检测肿瘤细胞外囊泡和癌症诊断。
Talanta. 2024 Dec 1;280:126780. doi: 10.1016/j.talanta.2024.126780. Epub 2024 Aug 24.
4
Enhancing sensitivity towards electrochemical miRNA detection using an affordable paper-based strategy.利用经济实惠的基于纸张的策略提高电化学 miRNA 检测的灵敏度。
Anal Bioanal Chem. 2024 Aug;416(19):4227-4236. doi: 10.1007/s00216-024-05406-6. Epub 2024 Jun 20.
5
Cascade CRISPR/Cas12a and DSN for the electrochemical biosensing of miR-1246 in BC-derived exosomes.级联 CRISPR/Cas12a 和 DSN 用于电化学生物传感 BC 衍生外泌体中的 miR-1246。
Bioelectrochemistry. 2024 Oct;159:108753. doi: 10.1016/j.bioelechem.2024.108753. Epub 2024 May 31.
6
SERS biosensors for liquid biopsy towards cancer diagnosis by detection of various circulating biomarkers: current progress and perspectives.用于液体活检的表面增强拉曼散射生物传感器通过检测各种循环生物标志物进行癌症诊断:当前进展与展望
Nano Converg. 2024 May 29;11(1):22. doi: 10.1186/s40580-024-00428-3.
7
MicroLOCK: Highly stable microgel biosensor using locked nucleic acids as bioreceptors for sensitive and selective detection of let-7a.MicroLOCK:使用锁定核酸作为生物受体的高稳定微凝胶生物传感器,用于灵敏和选择性检测 let-7a。
Biosens Bioelectron. 2024 Sep 15;260:116406. doi: 10.1016/j.bios.2024.116406. Epub 2024 May 23.
8
CRISPR/Cas12a and aptamer-chemiluminescence based analysis for the relative abundance determination of tumor-related protein positive exosomes for breast cancer diagnosis.基于 CRISPR/Cas12a 和适体-化学发光的分析用于乳腺癌诊断中肿瘤相关蛋白阳性外泌体的相对丰度测定。
Biosens Bioelectron. 2024 Sep 1;259:116380. doi: 10.1016/j.bios.2024.116380. Epub 2024 May 11.
9
Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation.液体活检技术与肺癌:诊断、监测与评估。
J Exp Clin Cancer Res. 2024 Apr 1;43(1):96. doi: 10.1186/s13046-024-03026-7.
10
Paper-based electrochemical device for early detection of integrin αvβ6 expressing tumors.用于早期检测整合素αvβ6表达肿瘤的纸质电化学装置。
Commun Chem. 2024 Mar 21;7(1):60. doi: 10.1038/s42004-024-01144-z.